DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

Virology

Volumn 266, Issue 2, 2000, Pages 329-339

  Hooper, J W ^a   Custer, D M ^a   Schmaljohn, C S ^a   Schmaljohn, A L ^a  

^a Dept of Immunol and Molec Biology Bldg 1425 U States Army Med R   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GENE PRODUCT; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; GENE GUN; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; POXVIRUS; PRIORITY JOURNAL; SMALLPOX; VACCINATION; VACCINIA VIRUS; VIRION; VIRUS GENE; VIRUS NEUTRALIZATION;

ANIMALIA; CYTOMEGALOVIRUS; DNA VIRUSES; POXVIRIDAE; VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 0034688332     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0096     Document Type: Article

References (27)

1. Blasco R., Moss B. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37000-Dalton outer envelope protein. J. Virol. 65:1991;5910-5920.
2. Breman J. G., Henderson D. A. Poxvirus dilemmas-monkeypox, smallpox, andbiologic terrorism. N. Engl. J. Med. 339:1998;556-559.
3. Cudmore S., Cossart P., Griffiths G., Way M. Actin-based motility of vaccinia virus. Nature. 378:1995;636-638.
4. Demkowicz W. E., Maa J. S., Esteban M. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J. Virol. 66:1992;386-398.
5. Eisenbraun M. D., Fuller D. H., Haynes J. R. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12:1993;791-797.
6. Franke C. A., Wilson E. M., Hruby D. E. Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25. J. Virol. 64:1990;5988-5996.
7. Galmiche M. C., Goenaga J., Wittek R., Rindisbacher L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology. 254:1999;71-80.
8. Gordon J., Mohandas A., Wilton S., Dales S. A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope. Virology. 181:1991;671-686.
9. Gregoriadis G. Genetic vaccines: Strategies for optimization. Pharmacol. Res. 15:1998;661-670.
10. Hollinshead M., Vanderplasschen A., Smith G. L., Vaux D. J. Vaccinia virus intracellular mature virions contain only one lipid membrane. J. Virol. 73:1999;1503-1517.
11. Hsiao J. C., Chung C. S., Chang W. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J. Virol. 73:1999;8750-8761.
12. Ichihashi Y., Takahashi T., Oie M. Identification of a vaccinia virus penetration protein. Virology. 202:1994;834-843.
13. Lai C. F., Gong S. C., Esteban M. The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J. Virol. 65:1991;5631-5635.
14. Massung R. F., Liu L. I., Qi J., Knight J. C., Yuran T. E., Kerlavage A. R., Parsons J. M., Venter J. C., Esposito J. J. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975. Virology. 201:1994;215-240.
15. McClain D. J., Harrison S., Yeager C. L., Cruz J., Ennis F. A., Gibbs P., Wright M. S., Summers P. L, Arthur J. D., Graham J. A. J. Infect. Dis. 175:1997;756-763.
16. Moss B. Poxviridae: The viruses and their replication. Knipe D. M., Fields B. N., Howley P. M. Fields Virology. 1996;2637-2671 Lippincott-Raven, Philadelphia.
17. Payne L. G. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 50:1980;89-100.
18. Payne L. G. Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation. Virology. 187:1992;251-260.
19. Pertmer T. M., Eisenbraun M. D., McCabe D., Prayaga S. K., Fuller D. H., Haynes J. R. Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine. 13:1995;1427-1430.
20. Ravanello M. P., Franke C. A., Hruby D. E. An NH2-terminal peptide from the vaccinia virus L1R protein directs the myristylation and virion envelope localization of a heterologous fusion protein. J. Biol. Chem. 268:1993;7585-7593.
21. Ravanello M. P., Hruby D. E. Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope. J. Gen. Virol. 75:1994;1479-1483.
22. Rodriguez J. F., Esteban M. Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J. Virol. 61:1987;3550-3554.
23. Roper R. L., Payne L. G., Moss B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 70:1996;3753-3762.
24. Roper R. L., Wolffe E. J., Weisberg A., Moss B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-tocell spread of vaccinia virus. J. Virol. 72:1998;4192-4204.
25. Schmaljohn C., Vanderzanden L., Bray M., Custer D., Meyer B., Li D., Rossi C., Fuller D., Fuller J., Haynes J., Huggins J. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:1997;9563-9569.
26. Schmelz M., Sodeik B., Ericsson M., Wolffe E. J., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:1994;130-147.
27. Wolffe E. J., Vijaya S., Moss B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology. 211:1995;53-63.